tiprankstipranks
Legend Biotech reports results from Phase 2 CARTITUDE-2 Cohort D Study
PremiumThe FlyLegend Biotech reports results from Phase 2 CARTITUDE-2 Cohort D Study
1M ago
Legend Biotech price target lowered to $73 from $86 at H.C. Wainwright
PremiumThe Fly
Legend Biotech price target lowered to $73 from $86 at H.C. Wainwright
1M ago
Legend Biotech Unveils New Myeloma Treatment Data
PremiumCompany Announcements
Legend Biotech Unveils New Myeloma Treatment Data
1M ago
Legend Biotech’s Strong Q1 Growth and Strategic Expansion
PremiumCompany AnnouncementsLegend Biotech’s Strong Q1 Growth and Strategic Expansion
2M ago
Legend Biotech reports Q1 EPS (16c), consensus (34c)
PremiumThe Fly
Legend Biotech reports Q1 EPS (16c), consensus (34c)
2M ago
LEGN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LEGN Upcoming Earnings Report: What to Expect?
2M ago
Scotiabank upgrades Legend Biotech on attractive entry point
PremiumThe FlyScotiabank upgrades Legend Biotech on attractive entry point
3M ago
Legend Biotech upgraded to Outperform from Sector Perform at Scotiabank
PremiumThe Fly
Legend Biotech upgraded to Outperform from Sector Perform at Scotiabank
3M ago
J&J report ‘not alarming’ for Legend Biotech, says H.C. Wainwright
PremiumThe Fly
J&J report ‘not alarming’ for Legend Biotech, says H.C. Wainwright
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100